Outcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir

Authors

  • Dr. Shailendranath Biswas

  • Dr. S K Ballav

  • Dr. Sheikh Farid Uddin Ahmed

  • Dr. Utpal Kumar Chanda

  • Dr.Tahmida Khanom

  • Dr. Mohaiminul Haque

Keywords:

SARS-CoV-2, oximetry, mechanical ventilation, radiological improvement

Abstract

Abstract not found

How to Cite

Outcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir. (2021). Global Journal of Medical Research, 21(K7), 1-9. https://doi.org/10.34257/GJMRKVOL21IS7PG1

References

Stanley Perlman (2020) Another Decade, Another Coronavirus. 382(8), 760-762.

Yosra Helmy, Mohamed Fawzy, Ahmed Elaswad, Ahmed Sobieh, Scott Kenney, Awad Shehata (2020) The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. 9(4), 1225.

Moira Chan‐yeung, Rui‐heng Xu (2003) SARS: epidemiology. 8(s1), 9-S14.

Shashank Joshi, Jalil Parkar, Abdul Ansari, Agam Vora, Deepak Talwar, Mangesh Tiwaskar, Saiprasad Patil, Hanmant Barkate (2020) Role of favipiravir in the treatment of COVID-19. 102, 501-508.

A Pg (2020) Coronavirus COVID-19 (SARS-CoV-2). 19, 1-17.

V Yan, F Muller (2020) Metropole de Lyon unveils the 14 winners of its Appel des 30. 2020(11), 6.

Timothy Sheahan, Amy Sims, Sarah Leist, Alexandra Schäfer, John Won, Ariane Brown, Stephanie Montgomery, Alison Hogg, Darius Babusis, Michael Clarke, Jamie Spahn, Laura Bauer, Scott Sellers, Danielle Porter, Joy Feng, Tomas Cihlar, Robert Jordan, Mark Denison, Ralph Baric (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. 11(1).

Maria Agostini, Erica Andres, Amy Sims, Rachel Graham, Timothy Sheahan, Xiaotao Lu, Everett Smith, James Case, Joy Feng, Robert Jordan, Adrian Ray, Tomas Cihlar, Dustin Siegel, Richard Mackman, Michael Clarke, Ralph Baric, Mark Denison (2018) Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. 9(2), 1-15.

Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. 30(3), 269-271.

Emmie De Wit, Friederike Feldmann, Jacqueline Cronin, Robert Jordan, Atsushi Okumura, Tina Thomas, Dana Scott, Tomas Cihlar, Heinz Feldmann (2020) Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. 117(12), 6771-6776.

Who (2020) COVID-19 statistical report - 18 November 2020.

F Lamontagne (2020) A living WHO guideline on drugs for covid-19. 370.

Dghs (2020) More US COVID-19 aid may pass by November. 7.

(2020) Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. 383(21), 2030-2040.

John Beigel, Kay Tomashek, Lori Dodd, Aneesh Mehta, Barry Zingman, Andre Kalil, Elizabeth Hohmann, Helen Chu, Annie Luetkemeyer, Susan Kline, Diego Lopez De Castilla, Robert Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas Patterson, Roger Paredes, Daniel Sweeney, William Short, Giota Touloumi, David Lye, Norio Ohmagari, Myoung-Don Oh, Guillermo Ruiz-Palacios, Thomas Benfield, Gerd Fätkenheuer, Mark Kortepeter, Robert Atmar, C Creech, Jens Lundgren, Abdel Babiker, Sarah Pett, James Neaton, Timothy Burgess, Tyler Bonnett, Michelle Green, Mat Makowski, Anu Osinusi, Seema Nayak, H Lane (2020) Remdesivir for the Treatment of Covid-19 - Final Report. 383(19), 1813-1826.

Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lu, Huadong Li, Shuzhen Wang, Shunan Ruan, Chengqing Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick Hayden, Peter Horby, Bin Cao, Chen Wang (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. 395(10236), 1569-1578.

Christoph Spinner, Robert Gottlieb, Gerard Criner, José Arribas López, Anna Cattelan, Alex Soriano Viladomiu, Onyema Ogbuagu, Prashant Malhotra, Kathleen Mullane, Antonella Castagna, Louis Chai, Meta Roestenberg, Owen Tsang, Enos Bernasconi, Paul Le Turnier, Shan-Chwen Chang, Devi Sengupta, Robert Hyland, Anu Osinusi, Huyen Cao, Christiana Blair, Hongyuan Wang, Anuj Gaggar, Diana Brainard, Mark Mcphail, Sanjay Bhagani, Mi Ahn, Arun Sanyal, Gregory Huhn, Francisco Marty (2020) Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19. 324(11), 1048.

Outcome Assessment in Case of Severe COVID-19  Patients Treated with Remdesivir

Published

2021-11-10

How to Cite

Outcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir. (2021). Global Journal of Medical Research, 21(K7), 1-9. https://doi.org/10.34257/GJMRKVOL21IS7PG1